![](https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2025/02/a1-shutterstock_2310274007.jpg)
Johnson & Johnson to resume market release of Varipulse catheter in US
Johnson & Johnson is set to resume the limited market release of the Varipulse Catheter, a treatment option for atrial fibrillation (AFib), in the US. The temporary suspension of the device’s US rollout began on 5 January 2025, following reports of …